Form D · Other Technology

Fresca Medical, Inc.

San Clemente, CA · CIK 0001557686

Offering snapshot reported Apr 24, 2017 · SEC filing

Reported sold
$1.8M
Offering amount: $6M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 12, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 24, 2017Initial$1,804,361No comparison5SEC filing
Apr 28, 2016Amendment$3,026,221$295,523vs Mar 15, 201620SEC filing
Mar 15, 2016Amendment$2,730,698$968,341vs Jul 17, 201516SEC filing
Jul 17, 2015Initial$1,762,357No comparison9SEC filing
Mar 12, 2014Initial$902,340No comparison8SEC filing
Sep 12, 2012Initial$1,520,452No comparison22SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-285343
Series C Preferred Stock

Source: Form D, filed Apr 24, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eugene Chen Director
To Ki Cheung Director
John Cox Executive
Andrew Cragg Director
Bruce Feuchter Executive
George Wallace Director
Martin J. Waters Executive
Matthew Weil Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
1291 Puerta Del Sol, Ste 200
San Clemente, CA, 92673